IRTC
iRhythm Holdings, Inc. · Healthcare
Insiders bought $57K of iRhythm Holdings, Inc. in the last 12 months
1 insider bought on 1 day.
IRTC over the last year
Largest buyers, last 12 months
IRTC after insider buys
3 months after each buy, from the first price a copier could get.
3 buys since 2023 with 3 months of prices.
Congress
Members reported 1 trade in IRTC since 2025.
Every filing
189 insider filings since 2017, newest first
Daniel G. Wilson · EVP, Corp Dev Inv Rel
Brice Bobzien · CFO
Sumi Shrishrimal · EVP and Chief Risk Officer
Patrick Michael Murphy · CBO, CLO
Quentin S. Blackford · President and CEO
Mark J. Day · CTO
Daniel G. Wilson · EVP, Corp Dev Inv Rel
Daniel G. Wilson · EVP, Corp Dev Inv Rel
Quentin S. Blackford · President and CEO
Patrick Michael Murphy · CBO, CLO
Brice Bobzien · CFO
Chad Patterson · Chief Commercial Officer
Daniel G. Wilson · EVP, Corp Dev Inv Rel
Minang Turakhia · EVP, CMO and CSO
Sumi Shrishrimal · EVP and Chief Risk Officer
Daniel G. Wilson · EVP, Corp Dev Inv Rel
Patrick Michael Murphy · CLO, EVP RA, QA MrktAcs, Gov
Mark J. Day · CTO
Daniel G. Wilson · EVP, Strategy Corp Dev Inv Rel
Douglas Devine · COO
Daniel G. Wilson · EVP, Strategy Corp Dev Inv Rel
Douglas Devine · COO
Mark J. Day · CTO
Patrick Michael Murphy · CLO, EVP RA, QA MrktAcs, Gov
Daniel G. Wilson · EVP, Strategy Corp Dev Inv Rel
Quentin S. Blackford · President and CEO
Douglas Devine · COO
Daniel G. Wilson · EVP, Strategy Corp Dev Inv Rel
Douglas Devine · COO and CFO
Daniel G. Wilson · EVP, Strategy Corp Dev Inv Rel
Douglas Devine · COO and CFO
Merz Cathleen Noel Bairey · Director
Douglas Devine · COO and CFO
Daniel G. Wilson · EVP, Strategy Corp Dev Inv Rel
Douglas Devine · COO and CFO
David A Vort · Chief Commercial Officer
Daniel G. Wilson · EVP, Strategy Corp Dev Inv Rel
Kevin M King · Director
Mark J. Day · EVP, Research, Development
David A Vort · Chief Commercial Officer
Douglas Devine · COO and CFO
Daniel G. Wilson · EVP, Strategy Corp Dev Inv Rel
Mark J. Day · EVP, Research, Development
David A Vort · EVP, Sales
David A Vort · EVP, Sales
David A Vort · EVP, Sales
David A Vort · EVP, Sales
David A Vort · EVP, Sales
David A Vort · EVP, Sales
David A Vort · EVP, Sales
About iRhythm Holdings, Inc.
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.